Total Payments
$5,120
2024 Payments
$1,580
Companies
32
Transactions
169
Medicare Patients
8,689
Medicare Billing
$571,152
Payment Breakdown by Category
Food & Beverage$4,965 (97.0%)
Education$101.10 (2.0%)
Gifts$53.66 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,965 | 163 | 97.0% |
| Education | $101.10 | 5 | 2.0% |
| Gift | $53.66 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $528.87 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $449.11 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $401.19 | 14 | $0 (2024) |
| Amgen Inc. | $336.44 | 14 | $0 (2024) |
| ShockWave Medical, Inc | $313.51 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $272.22 | 10 | $0 (2024) |
| Boston Scientific Corporation | $252.66 | 3 | $0 (2023) |
| Medtronic, Inc. | $213.55 | 2 | $0 (2023) |
| Osprey Medical Inc | $206.03 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.12 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,580 | 49 | ShockWave Medical, Inc ($183.12) |
| 2023 | $1,321 | 26 | Medtronic, Inc. ($213.55) |
| 2022 | $24.00 | 2 | PFIZER INC. ($12.42) |
| 2021 | $378.18 | 7 | AstraZeneca Pharmaceuticals LP ($206.27) |
| 2020 | $44.40 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($44.40) |
| 2018 | $1,139 | 40 | Osprey Medical Inc ($206.03) |
| 2017 | $632.44 | 41 | Novartis Pharmaceuticals Corporation ($193.37) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $44.45 | General |
| Category: Genetic Disease | ||||||
| 11/26/2024 | ABIOMED | Impella (Device) | Gift | In-kind items and services | $53.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.18 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $126.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Cardiovascular | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiology | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: Cardiovascular | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: DIABETES | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,864 | 2,296 | $460,282 | $123,343 |
| 2022 | 20 | 2,208 | 2,894 | $597,016 | $155,311 |
| 2021 | 18 | 2,102 | 2,720 | $557,558 | $149,859 |
| 2020 | 21 | 2,515 | 3,202 | $553,316 | $142,639 |
Total Patients
8,689
Total Services
11,112
Medicare Billing
$571,152
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 191 | 260 | $106,411 | $34,394 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 371 | $117,960 | $31,770 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 221 | 223 | $43,308 | $11,029 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 174 | $36,346 | $10,767 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 91 | 91 | $37,796 | $8,914 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $22,940 | $4,944 | 21.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 47 | $13,927 | $3,811 | 27.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 66 | 66 | $15,906 | $3,629 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 259 | 321 | $17,820 | $3,504 | 19.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 116 | 184 | $11,040 | $2,774 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $10,472 | $2,537 | 24.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 91 | 91 | $6,165 | $1,382 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $4,536 | $999.57 | 22.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 107 | 180 | $3,060 | $756.00 | 24.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 70 | 70 | $3,220 | $707.58 | 22.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 87 | 102 | $5,508 | $624.29 | 11.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 18 | 18 | $1,440 | $360.72 | 25.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 19 | 19 | $1,558 | $228.00 | 14.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $869.00 | $212.85 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 379 | 535 | $173,340 | $46,601 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 124 | 148 | $64,676 | $20,345 | 31.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 149 | 152 | $63,840 | $16,417 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 277 | 283 | $55,185 | $14,981 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 104 | 171 | $54,549 | $13,861 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 103 | 146 | $32,266 | $8,309 | 25.8% |
About Dr. Jorge Cusco, MD
Dr. Jorge Cusco, MD is a Cardiovascular Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336100841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Cusco, MD has received a total of $5,120 in payments from pharmaceutical and medical device companies, with $1,580 received in 2024. These payments were reported across 169 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,965).
As a Medicare-enrolled provider, Cusco has provided services to 8,689 Medicare beneficiaries, totaling 11,112 services with total Medicare billing of $571,152. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Orlando, FL
- Active Since 04/01/2006
- Last Updated 11/28/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336100841
Products in Payments
- XARELTO (Drug) $526.34
- ENTRESTO (Drug) $410.42
- Repatha (Biological) $282.96
- FARXIGA (Drug) $264.19
- CAMZYOS (Drug) $232.67
- DyeVert (Device) $206.03
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $183.12
- Assure WCD (Device) $169.16
- Impella (Device) $163.04
- BodyGuardian (Device) $155.86
- PRADAXA (Drug) $154.74
- COREVALVE EVOLUT R (Device) $152.41
- NEXLETOL (Drug) $150.49
- SYNERGY ABLATION SYSTEM (Device) $144.67
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $130.39
- Resolute (Device) $119.26
- Livalo (Drug) $118.33
- BRILINTA (Drug) $117.94
- LifeVest (Device) $107.87
- RYBREVANT (Drug) $101.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orlando
Naveen Bellam, M.d, M.D
Cardiovascular Disease — Payments: $315,652
Cardiovascular Disease $315,652
Dr. Bruce Stein, Md, MD
Cardiovascular Disease — Payments: $291,287
Cardiovascular Disease $291,287
Carlos Zamora, M.d, M.D
Cardiovascular Disease — Payments: $215,909
Cardiovascular Disease $215,909
Nirav Raval, Md, MD
Cardiovascular Disease — Payments: $171,358
Cardiovascular Disease $171,358
James Tarver, M.d, M.D
Cardiovascular Disease — Payments: $133,743
Cardiovascular Disease $133,743
Aurelio Duran, M.d, M.D
Cardiovascular Disease — Payments: $110,928
Cardiovascular Disease $110,928